Highest risk of symptomatic venous thromboembolic events after radical cystectomy occurs in patients with obesity or nonurothelial cancers

Context: Venous thromboembolism (VTE) is a common cause of postoperative morbidity and mortality in cystectomy patients. Aims: The aim of this study is to identify variables associated with risk of developing deep venous thrombosis (DVT) or pulmonary embolism (PE) within 90 days after radical cystectomy (RC). Setting and Design: Retrospective chart review of patients undergoing RC from 2004 to 2011 at the University of Wisconsin. Subjects and Methods: Clinical variables collected for all RC patients. All patients received mechanical prophylaxis, and routine heparin prophylaxis began in 2010. Statistical Analysis Used: Univariate and multivariate analyses were used to evaluate VTE association with known risk factors. Results: A total of 241 patients were identified with median age of 67.1 (interquartile range: 57.8-74.3) years. Body mass index (BMI) was ≥30 in 36.8% of patients. Median blood loss was 950 (600-1500) mL and 157/241 (65.2%) patients received a blood transfusion. Within 90 days postoperatively, overall venous thromboembolic event (VTE) rate was 20/241 (8.3%). Of these, 13 (5 DVT, 8 PE) and 7 (3 DVT, 4 PE) were diagnosed on days 0-30 and days 31-90, respectively. After multivariate analysis, BMI ≥30 (odds ratio [OR] = 4.69, confidence interval [CI] = 1.70-12.92) and nonurothelial bladder cancer (OR = 4.01, CI = 1.33-12.07) were associated with significantly increased rates of VTE. Conclusions: Patients with BMI ≥30 or nonurothelial cancer are at highest risk for postoperative VTE and should be considered for extended heparin prophylaxis.

• Publication year

  2015

• Venue

  Urology Annals

• Publication date

  2015-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.4103/0974-7796.152050PMID 26229325PMCID 4518374
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Familiarity and self-reported compliance with American Urological Association best practice recommendations for use of thromboembolic prophylaxis among American Urological Association members.

  2013cited by this paper
• Incidence, risk profile and morphological pattern of lower extremity venous thromboembolism after urological cancer surgery.

  2011cited by this paper
• Risk factors for pelvic lymphoceles post‐radical prostatectomy

  2011cited by this paper
• Variation in thromboembolic complications among patients undergoing commonly performed cancer operations.

  2011cited by this paper
• Rates of Venous Thromboembolism Among Patients with Major Surgery for Cancer

  2011cited by this paper
• Surveillance for deep vein thrombosis and pulmonary embolism: recommendations from a national workshop.

  2010cited by this paper
• Incidence, risk profile and morphological pattern of venous thromboembolism after prostate cancer surgery

  2009cited by this paper
• Defining early morbidity of radical cystectomy for patients with bladder cancer using a standardized reporting methodology.

  2009cited by this paper
• Complications and mortality after radical cystectomy for bladder transitional cell cancer.

  2009cited by this paper
• AUA Best Practice Statement for the prevention of deep vein thrombosis in patients undergoing urologic surgery.

  2009cited by this paper
• Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

  2008cited by this paper
• Complications of pelvic lymphadenectomy in 1,380 patients undergoing radical retropubic prostatectomy between 1993 and 2006.

  2008cited by this paper
• Surgical complications following radical cystectomy and orthotopic neobladders in women.

  2008cited by this paper
• Perioperative complications of radical cystectomy in a contemporary series.

  2007cited by this paper
• Clinically overt venous thromboembolism after urologic cancer surgery: results from the @RISTOS Study.

  2007cited by this paper
• The rate of bleeding complications after pharmacologic deep venous thrombosis prophylaxis: a systematic review of 33 randomized controlled trials.

  2006cited by this paper
• A critical analysis of perioperative mortality from radical cystectomy.

  2006cited by this paper
• Analysis of early complications after radical cystectomy: results of a collaborative care pathway.

  2002cited by this paper
• Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer.

  2002cited by this paper
• Making health care safer: a critical analysis of patient safety practices.

  2001cited by this paper
• The changing pattern of mortality and morbidity from radical cystectomy

  2000cited by this paper
• Cost Effectiveness of the Prevention and Treatment of Deep Vein Thrombosis and Pulmonary Embolism

  1997cited by this paper
• Cost of Long-Term Complications of Deep Venous Thrombosis of the Lower Extremities: An Analysis of a Defined Patient Population in Sweden

  1997cited by this paper
• Is heparin contraindicated in pelvic lymphadenectomy and radical prostatectomy?

  1997cited by this paper
• Low molecular weight heparin and radical prostatectomy: a prospective analysis of safety and side effects

  1997cited by this paper
• Lymph leakage after staging pelvic lymphadenectomy for prostatic carcinoma with and without heparin prophylaxis.

  1994cited by this paper
• Prophylactic mini-dose heparin in patients undergoing radical retropubic prostatectomy. A prospective trial.

  1992cited by this paper
• Complications of low-dose heparin prophylaxis following pelvic lymphadenectomy.

  1986cited by this paper

• A nomogram predicting the risk of venous thromboembolism in patients following urologic surgeries

  2025cites this paper
• Extended thromboprophylaxis following major abdominal/pelvic cancer-related surgery: A systematic review and meta-analysis of the literature.

  2021cites this paper
• Prevalence and Predictors of Venous Thromboembolism after Robot-Assisted Radical Cystectomy.

  2020cites this paper
• The impact of preoperative nutritional status on post-surgical complication and mortality rates in patients undergoing radical cystectomy for bladder cancer: a systematic review of the literature

  2020cites this paper
• The role of extended venous thromboembolism prophylaxis for major urological cancer operations

  2019cites this paper
• Venous thromboprophylaxis in urological cancer surgery

  2019cites this paper
• Preoperative Incidence of Deep Venous Thrombosis in Patients With Bladder Cancer Undergoing Radical Cystectomy.

  2018cites this paper
• Venous thromboembolism prophylaxis in cancer patients — guidelines focus on surgical patients

  2017cites this paper
• Extended outpatient chemoprophylaxis reduces venous thromboembolism after radical cystectomy.

  2017cites this paper
• Preoperative nutritional factors and outcomes after radical cystectomy: A narrative review.

  2017cites this paper
• Risk factors for deep venous thrombosis in patients with acute stroke

  2016cites this paper
• Muscle-invasive and Metastatic Bladder Cancer EAU Guidelines on

  2016cites this paper
• Morbidity After Inguinal Lymph Node Dissections: It Is Time for a Change

  2016cites this paper